Kathleen McKillip, MD
Hospice and Palliative Medicine · Omaha, NENPI 1629416177
Payments from drug & device makers
Across 18 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ADC Therapeutics America, Inc.$57
- Regeneron Healthcare Solutions, Inc.$51
- Novartis$34
- Daiichi Sankyo Inc.$34
- E.r. Squibb & Sons, L.L.C.$21
- Merck$21
- plus $152 from 9 others
What the payments were for
- Food & beverage$370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ADC Therapeutics America, Inc. | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Novartis | 1 | $34 |
| Daiichi Sankyo Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Merck | 1 | $21 |
| Genmab U.S., Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| AbbVie | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $14 |
| Eisai Inc. | 1 | $14 |
How this compares
Too few hospice and palliative medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 85 | $2,597 |
| Fentanyl | 17 | $1,772 |
| Morphine Sulfate ErMorphine Sulfate | 23 | $1,161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $1,050 |
| Naloxone Hcl | 17 | $1,008 |
| Olanzapine | 23 | $728 |
| Morphine Sulfate | 20 | $502 |
| Hydromorphone Hcl | 23 | $250 |
| Gabapentin | 21 | $135 |
| Mirtazapine | 13 | $96 |
| Alprazolam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Omaha
- Maya GogtayOmaha$2K
- Sami ZeineddineOmaha$396
- James WaxBellevue$18K
- Amanda WoodwardLincoln$651
- Melissa JohnsonLincoln$48
- Connie BeehlerScottsbluff$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.